weight-loss and diet control industry
NewslettersExclusive: The founders of SoulCycle built a startup for relationships, then pivoted to GLP-1 support groups. Now its assets are being acquired by WeightWatchers
By Emma HinchliffeAugust 7, 2025
HealthThe key to a long life is avoiding the ‘poisonous 5 P’s,’ says one of the world’s top anti-aging experts
By Alexa MikhailMay 24, 2025
By Eric Pfanner and BloombergMay 16, 2025
By Jonel Aleccia and The Associated PressMay 12, 2025
HealthCurrency hedging and new U.S. factories: Novo Nordisk CFO thinks Wegovy maker can outmaneuver global trade wars
By Ryan HoggMay 9, 2025
FinanceWeightWatchers files for bankruptcy as it struggles for a place in a weight loss world dominated by Ozempic and Wegovy
By The Associated PressMay 7, 2025
By Bloomberg, Madison Muller, Ike Swetlitz and Naomi KresgeFebruary 21, 2025
FinanceWeight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
By Ryan HoggFebruary 19, 2025
HealthThe dietary supplements you think are improving your health may be damaging your liver, research warns
By Lindsey LeakeFebruary 18, 2025
By Lindsey LeakeFebruary 11, 2025
HealthAs growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs
By Ryan HoggFebruary 5, 2025
HealthInvestors are growing anxious about Novo Nordisk’s silence since disappointing CagriSema weight loss drug results
By Ryan HoggFebruary 4, 2025
Most Popular
